Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Dorval

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
BMJ Open|March 1, 2018
Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Québec (Canada)Jolyane Blouin-Bougie, Nabil Amara, Karine Bouchard, et al.
Journal of Genetic Counseling|September 17, 2017
Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone-Based Peer Support InterventionD St-Pierre, K Bouchard, L Gauthier, et al.
Familial Cancer|November 15, 2011
Self-reported mammography use following BRCA1/2 genetic testing may be overestimatedGeneviève Larouche, Karine Bouchard, Jocelyne Chiquette, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|June 20, 2016
Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation CarriersGeneviève Larouche, Jocelyne Chiquette, Marie Plante, et al.
Journal of Genetic Counseling|August 16, 2012
Life events may contribute to family communication about cancer risk following BRCA1/2 testingJulie Lapointe, Claudia Côté, Karine Bouchard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testingMichel Dorval, Marie-Hélène Vallée, Marie Plante, et al.
Psychological Reports|August 29, 2006
Using the impact of event scale to evaluate distress in the context of genetic testing for breast cancer susceptibilityMichel Dorval, Mélanie Drolet, Mélanie LeBlanc, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2012
Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up studyJulie Lapointe, Karine Bouchard, Andrea Farkas Patenaude, et al.
Journal of Cancer Survivorship : Research and Practice|September 26, 2009
Patterns of confidant use among patients and spouses in the year after breast cancerElizabeth Maunsell, Stéphane Guay, Evelyne Yandoma, et al.
Cancer Medicine|January 9, 2024
Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative studyJosée Savard, Catherine Filion, Claudia Mc Brearty, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
BMJ Open|March 1, 2018
Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Québec (Canada)Jolyane Blouin-Bougie, Nabil Amara, Karine Bouchard, et al.
Journal of Genetic Counseling|September 17, 2017
Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone-Based Peer Support InterventionD St-Pierre, K Bouchard, L Gauthier, et al.
Familial Cancer|November 15, 2011
Self-reported mammography use following BRCA1/2 genetic testing may be overestimatedGeneviève Larouche, Karine Bouchard, Jocelyne Chiquette, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|June 20, 2016
Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation CarriersGeneviève Larouche, Jocelyne Chiquette, Marie Plante, et al.
Journal of Genetic Counseling|August 16, 2012
Life events may contribute to family communication about cancer risk following BRCA1/2 testingJulie Lapointe, Claudia Côté, Karine Bouchard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testingMichel Dorval, Marie-Hélène Vallée, Marie Plante, et al.
Psychological Reports|August 29, 2006
Using the impact of event scale to evaluate distress in the context of genetic testing for breast cancer susceptibilityMichel Dorval, Mélanie Drolet, Mélanie LeBlanc, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2012
Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up studyJulie Lapointe, Karine Bouchard, Andrea Farkas Patenaude, et al.
Journal of Cancer Survivorship : Research and Practice|September 26, 2009
Patterns of confidant use among patients and spouses in the year after breast cancerElizabeth Maunsell, Stéphane Guay, Evelyne Yandoma, et al.
Cancer Medicine|January 9, 2024
Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative studyJosée Savard, Catherine Filion, Claudia Mc Brearty, et al.
Pageof 9